Mersana Therapeutics, Inc.
MRSNDelisted Jan 6, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001442836
Mersana Therapeutics, Inc. was delisted on Jan 6, 2026; its insiders filed their last Form 4 on Jan 6, 2026; 51 institutions reported holding it in 13F filings for Q4 2025, worth $64.8M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Mersana Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 147 | 128 | −19 |
| Shares | 112.5M | 113.7M | +1.24M (+1.1%) |
| Value | $370.2M | $144.4M | −$225.8M (−61.0%) |
New holders (26)
Institutions that held Mersana Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (45)
Institutions that held Mersana Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.